This morning, in one of my favourite blogs, 'Confused of Calcutta', I noticed a recent post I had missed:
Some of this might also be applied to the white elephant in the room that is Pharma, or perhaps some might think an ostrich in the sand might be more apt, yet an email from a friend brought me this interesting link on ADHD, showing a new information site on Facebook:
It was created by J&J's company, McNeil Pediatrics. Although ADHD is common in children, apparently 9M adults also suffer from the condition. The site is interesting because Facebook's new structure allows them to customise the tabs for different sets of information and education, including managing time and work overload/concentration issues. There are podcasts, links to experts, self assessment questionnaires and all sorts of other tools for sufferers to try out.
There is also a nifty Facebook feature that allows people to become a 'fan' of such site pages and thus virally spread the word, since others will see the notifications that X became a fan of Y in their Facebook lifestream. It will be interesting to see how the concept develops over time. It's not exactly direct engagement per se, but it's certainly a step in the right direction.